Exelixis
EXEL
#1659
Rank
โ‚ฌ10.61 B
Marketcap
39,45ย โ‚ฌ
Share price
0.54%
Change (1 day)
22.92%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company